Literature DB >> 11748371

Vestibular schwannoma with malignant transformation: a case report.

E I Son1, I M Kim, S P Kim.   

Abstract

We describe a rare case of malignant transformation in a vestibular schwannoma in a 33-yr-old woman. She presented herself with headache, tinnitus, and hearing loss and underwent posterior fossa explorations three times during the short period of 3 months. The clinicopathological features of the original tumor were typical of benign vestibular schwannoma. Despite a complete microsurgical excision, two months later, the tumor recurred locally with a rapid increase in size causing a progressive worsening of neurological symptoms. A diagnosis of malignant schwannoma was made for the recurrent tumor on the basis of the microscopic findings of high cellularity, moderate pleomorphism, and the presence of mitotic cells. Repeat magnetic resonance imaging performed a month after the second surgery unexpectedly showed definite tumor enlargement. She remained clinically stable following the third debulking of the tumor and adjuvant radiotherapy. We propose that this recurrent tumor represent malignant transformation from a benign vestibular schwannoma which was an unusual occurrence in a patient without neurofibromatosis.

Entities:  

Mesh:

Year:  2001        PMID: 11748371      PMCID: PMC3054799          DOI: 10.3346/jkms.2001.16.6.817

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  8 in total

1.  MALIGNANT TRANSFORMATION OF CRANIAL NERVE SCHWANNOMA AFTER RADIOSURGERY - CASE REPORT.

Authors:  A B Bah; O D N'dri; A Herbrecht; F Parker
Journal:  J West Afr Coll Surg       Date:  2014 Apr-Jun

2.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

3.  Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery.

Authors:  Andreas K Demetriades; Nicholas Saunders; Peter Rose; Cyril Fisher; Jeremy Rowe; Robert Tranter; Carl Hardwidge
Journal:  Skull Base       Date:  2010-09

4.  Delayed microsurgery for vestibular schwannoma after gamma knife radiosurgery.

Authors:  Cheng-Chia Lee; Yu-Shu Yen; David Hung-Chi Pan; Wen-Yuh Chung; Hsin-Mei Wu; Wan-Yuo Guo; Ming-Te Chen; Kang-Du Liu; Yang-Hsin Shih
Journal:  J Neurooncol       Date:  2010-04-20       Impact factor: 4.130

5.  AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.

Authors:  Matthew L Bush; Janet Oblinger; Victoria Brendel; Griffin Santarelli; Jie Huang; Elena M Akhmametyeva; Sarah S Burns; Justin Wheeler; Jeremy Davis; Charles W Yates; Abhik R Chaudhury; Samuel Kulp; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling; Abraham Jacob
Journal:  Neuro Oncol       Date:  2011-07-21       Impact factor: 12.300

6.  Spontaneous Transformation of Vestibular Schwannoma into Malignant Peripheral Nerve Sheath Tumor.

Authors:  Artem Belyaev; Dmitry Usachev; Vadim Shimansky; Dzhemil Odamanov; Lyudmila Shishkina; Marina Ryzhova; Andrey Golanov
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep

7.  Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors.

Authors:  Bénédicte L'heureux-Lebeau; Issam Saliba
Journal:  Onco Targets Ther       Date:  2013-04-26       Impact factor: 4.147

8.  Schwannoma Located in Nasopharyngeal Region.

Authors:  Fadlullah Aksoy; Alper Yenigun; Erol Senturk; Orhan Ozturan
Journal:  Case Rep Otolaryngol       Date:  2016-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.